馬玉林 吳純斌
靜吸復(fù)合麻醉和全憑靜脈麻醉對(duì)行腹腔鏡胃癌根治術(shù)患者血?dú)饧懊庖吖δ艿挠绊?/p>
馬玉林 吳純斌
目的 研究靜吸復(fù)合麻醉和全憑靜脈麻醉對(duì)行腹腔鏡胃癌根治術(shù)患者血?dú)饧懊庖吖δ艿挠绊?。方?選擇80例胃癌患者,均采取腹腔鏡胃癌根治術(shù)治療,按照麻醉方法的不同分為觀察組和對(duì)照組,觀察組采用靜吸復(fù)合麻醉,對(duì)照組采用全憑靜脈麻醉。觀察2組麻醉前后的免疫功能,以及CO2氣腹前后血?dú)夥治龅淖兓?。結(jié)果 術(shù)畢2組的NK、CD3+、CD4+和CD4+/CD8+水平均較麻醉前明顯降低(P<0.05),且對(duì)照組的下降幅度更為明顯(P<0.05);術(shù)后 72 h 2組的免疫功能指標(biāo)均較術(shù)畢時(shí)明顯升高(P<0.05)。觀察組氣腹前后的血?dú)夥治鰺o(wú)明顯差異(P>0.05),對(duì)照組氣腹后pH值明顯降低(P<0.05),CO2分壓、堿剩余和CO2總量明顯升高(P<0.05),且觀察組氣腹后的血?dú)夥治雠c對(duì)照組之間有明顯差異(P<0.05)。結(jié)論 靜吸復(fù)合麻醉較全憑靜脈麻醉,對(duì)行腹腔鏡胃癌根治術(shù)患者的免疫功能影響較小,患者術(shù)中血?dú)夥治鲋笜?biāo)平穩(wěn)。
靜吸復(fù)合麻醉;全憑靜脈麻醉;腹腔鏡胃癌根治術(shù);血?dú)?;免疫功?/p>
(ThePracticalJournalofCancer,2017,32:048~050)
胃癌是臨床較為常見的1種消化道惡性腫瘤,根治性手術(shù)切除是治愈胃癌的最佳途徑。在胃癌患者手術(shù)治療中,腹腔鏡胃癌根治術(shù)的應(yīng)用日趨廣泛。腹腔鏡胃癌根治術(shù)不但可以達(dá)到與傳統(tǒng)開腹手術(shù)相同的淋巴結(jié)清掃范圍及手術(shù)切除范圍,而且具有清除徹底、創(chuàng)傷小、胃腸道干擾小、手術(shù)視野好、切口瘢痕小、恢復(fù)快、術(shù)后并發(fā)癥少等優(yōu)點(diǎn)[1-2]。胃癌患者多存在不同程度的免疫功能異常,外科手術(shù)引起的應(yīng)激反應(yīng)會(huì)降低機(jī)體的免疫功能,使手術(shù)過(guò)程中細(xì)胞微栓的存活率升高,促進(jìn)腫瘤細(xì)胞的生長(zhǎng)和轉(zhuǎn)移,因此選擇合適的麻醉方法能有效降低術(shù)中的應(yīng)激反應(yīng),改善機(jī)體免疫功能[3]。本研究對(duì)比分析了靜吸復(fù)合麻醉和全憑靜脈麻醉對(duì)行腹腔鏡胃癌根治術(shù)患者免疫功能和血?dú)夥治龅挠绊?,現(xiàn)報(bào)告如下。
1.1 一般資料
選擇2014年1月至2015年9月在我院進(jìn)行診治的胃癌患者80例,所有患者均符合麻醉醫(yī)師學(xué)會(huì)(ASA)Ⅰ~Ⅱ級(jí)的診斷標(biāo)準(zhǔn),且均進(jìn)行腹腔鏡胃癌根治術(shù)治療。按照麻醉方法的不同分為觀察組和對(duì)照組。觀察組40例,男性26例,女性14例;年齡35~78歲,平均(53.26±9.13)歲;平均術(shù)中出血量為(185.37±52.35)ml;平均手術(shù)時(shí)間為(115.42±28.37)min。對(duì)照組40例,男性25例,女性15例;年齡36~79歲,平均(52.86±8.37)歲;平均術(shù)中出血量為(192.58±51.42)ml;平均手術(shù)時(shí)間為(118.79±23.52)min。本研究獲得我院倫理委員會(huì)的批準(zhǔn),所有患者均簽署知情同意書。2組的基線資料具有可比性。
1.2 麻醉方法
術(shù)前常規(guī)肌肉注射阿托品0.5 mg和巴比妥鈉0.1 mg。進(jìn)入手術(shù)室后連續(xù)監(jiān)測(cè)患者的心電圖、腦電雙頻指數(shù)、血壓、心率和氧分壓。觀察組麻醉誘導(dǎo):靜脈注射咪唑安定 0.2 mg/kg,維庫(kù)溴銨0.1 mg/kg,芬太尼 4~6 μg/kg;麻醉維持:持續(xù)泵注順式阿曲庫(kù)銨0.1~0.2 mg·kg-1·h-1和瑞芬太尼0.1~0.2 μg·kg-1·min-1,吸入2%~3%七氟醚,控制呼吸為12~15次/min。對(duì)照組麻醉誘導(dǎo):芬太尼 3 μg/kg,順式阿曲庫(kù)胺 0.1 mg/kg;麻醉維持:持續(xù)泵注瑞芬太尼0.04~0.4 μg·kg-1·min-1。
1.3 觀察指標(biāo)
分別于麻醉前、手術(shù)結(jié)束時(shí)和術(shù)后72 h采集3 ml肘靜脈血,用流式細(xì)胞儀檢測(cè)NK 細(xì)胞、CD3+、CD4+和CD4+/CD8+水平。并于CO2氣腹前后抽取橈動(dòng)脈血進(jìn)行血?dú)夥治?,檢測(cè) CO2分壓、pH、堿剩余和CO2總量。
1.4 統(tǒng)計(jì)學(xué)分析
2.1 2組免疫功能比較
術(shù)畢2組的NK、CD3+、CD4+和CD4+/CD8+水平均較麻醉前明顯降低(P<0.05),且對(duì)照組的下降幅度更為明顯(P<0.05),術(shù)后72 h 2組的免疫功能指標(biāo)均較術(shù)畢時(shí)明顯升高(P<0.05),見表1。
表1 2組免疫功能比較
*為與對(duì)照組術(shù)畢相比,P<0.05;#為與同組術(shù)前相比,P<0.05;﹢為同組與術(shù)畢相比,P<0.05。
2.2 2組血?dú)夥治銮闆r比較
觀察組氣腹前后的血?dú)夥治鰺o(wú)明顯差異(P>0.05)。對(duì)照組氣腹后pH值明顯降低(P<0.05),CO2分壓、堿剩余和CO2總量明顯升高(P<0.05),且觀察組氣腹后的血?dú)夥治雠c對(duì)照組之間有明顯差異(P<0.05),見表2。
表2 2組血?dú)夥治銮闆r比較±s)
*為與對(duì)照組氣腹后相比,P<0.05;#為與同組氣腹前相比,P<0.05。
胃癌是指發(fā)生在胃上皮組織的惡性腫瘤,是世界范圍內(nèi)最為常見的消化道惡性腫瘤,也是導(dǎo)致人類死亡的第二大腫瘤[4]。腹腔鏡胃癌根治術(shù)在術(shù)中可觀察腫瘤的大小、位置和浸潤(rùn)轉(zhuǎn)移情況,降低術(shù)中出血量,減輕術(shù)后疼痛,術(shù)后恢復(fù)較快[5]。腹腔鏡手術(shù)的快速發(fā)展,進(jìn)一步提高了對(duì)麻醉的要求。當(dāng)受到麻醉、手術(shù)、術(shù)中輸血和術(shù)后疼痛等刺激后,機(jī)體會(huì)釋放兒茶酚胺、腎上腺皮質(zhì)激素、細(xì)胞因子及糖皮質(zhì)激素等,進(jìn)而促進(jìn)免疫調(diào)節(jié)性物質(zhì)β-內(nèi)啡肽的合成及釋放,產(chǎn)生免疫抑制作用[6]。麻醉方法不同對(duì)患者機(jī)體的呼吸和循環(huán)的影響也不同,因此,研究不同麻醉方法對(duì)患者免疫功能和血?dú)夥治龅挠绊?,探討麻醉在胃癌腹腔鏡手術(shù)中的效果與安全性具有重要的臨床意義。
檢測(cè)外周血中 T 淋巴細(xì)胞亞群水平是反映機(jī)體細(xì)胞免疫功能的重要方法。本研究發(fā)現(xiàn),術(shù)畢2組的NK、CD3+、CD4+和CD4+/CD8+水平均較麻醉前明顯降低(P<0.05),且對(duì)照組的下降幅度更為明顯(P<0.05),術(shù)后 72 h 2組的免疫功能指標(biāo)均較術(shù)畢時(shí)明顯升高(P<0.05),提示麻醉及手術(shù)對(duì)患者免疫功均會(huì)造成不同程度的抑制,而免疫功能的抑制會(huì)升高術(shù)后傷口感染和腫瘤細(xì)胞轉(zhuǎn)移的發(fā)生率。手術(shù)麻醉引起的應(yīng)激反應(yīng)是導(dǎo)致圍手術(shù)期免疫功能抑制的重要原因,可以通過(guò)促進(jìn)垂體、下丘腦中兒茶酚胺和腎上腺激素的分泌及釋放,抑制機(jī)體免疫功能[7]。靜吸復(fù)合麻醉對(duì)患者機(jī)體免疫功能的影響程度較輕,與應(yīng)激反應(yīng)的發(fā)生程度密切相關(guān)[8]。腹腔鏡手術(shù)耗時(shí)較長(zhǎng)、手術(shù)較復(fù)雜、技術(shù)要求較高,對(duì)機(jī)體的應(yīng)激反應(yīng)造成一定程度的影響。靜吸復(fù)合麻醉與全憑靜脈麻醉相比可以減輕神經(jīng)的興奮性,降低患者機(jī)體皮質(zhì)類固醇激素及兒茶酚胺水平,抑制手術(shù)所導(dǎo)致的應(yīng)激反應(yīng)[9]。因腹腔鏡胃癌根治術(shù)后患者機(jī)體的應(yīng)激反應(yīng)需持續(xù)48~72 h,術(shù)后 72 h免疫功能就可以恢復(fù)至術(shù)前水平。
在進(jìn)行腹腔鏡胃癌根治術(shù)時(shí)需要建立氣腹,以最大程度地?cái)U(kuò)大手術(shù)操作空間,并使術(shù)中視野更加清晰[10]。CO2的高彌散性會(huì)對(duì)患者的循環(huán)、呼吸、腎臟及神經(jīng)系統(tǒng)等功能造成影響。CO2的吸收程度受腹壓的影響,腹壓升高造成pH值降低,CO2分壓升高[11]。本研究發(fā)現(xiàn),觀察組氣腹前后的血?dú)夥治鰺o(wú)明顯差異(P>0.05),對(duì)照組氣腹后pH值明顯降低(P<0.05),CO2分壓、堿剩余和CO2總量明顯升高(P<0.05),且觀察組氣腹后的血?dú)夥治雠c對(duì)照組之間有明顯差異(P<0.05),提示靜吸復(fù)合麻醉對(duì)患者氣腹后血?dú)夥治鲇绊戄^小,有利于手術(shù)的順利進(jìn)行。
綜上所述,靜吸復(fù)合麻醉較全憑靜脈麻醉,對(duì)行腹腔鏡胃癌根治術(shù)患者的免疫功能影響較小,患者術(shù)中血?dú)夥治鲋笜?biāo)平穩(wěn)。
[1] 李正東,陳本鑫,陳霖霖.腹腔鏡遠(yuǎn)端胃癌D2根治術(shù)的臨床分析〔J〕.實(shí)用癌癥雜志,2013,28(6):683-685.
[2] 吳 暉.腹腔鏡胃癌根治術(shù)對(duì)患者綜合生存質(zhì)量、免疫及應(yīng)激狀態(tài)的影響〔J〕.海南醫(yī)學(xué)院學(xué)報(bào),2014,20(1):99-102.
[3] 馬長(zhǎng)華,袁林輝,李 昌,等.胃癌手術(shù)老年患者不同麻醉方案免疫功能比較〔J〕.重慶醫(yī)學(xué),2015,44(29):4138-4140.
[4] Lordick F,Hoffmeister A.Treatment of gastric cancer 〔J〕.Der Internist,2014,55(1):82-89.
[5] Tsunoda S,Okabe H,Tanaka E,et al.Laparoscopic gastrectomy for remnant gastric cancer:a comprehensive review and case series〔J〕.Gastric Cancer,2014,19(1):1-6.
[6] Uzun S,Yuce Y,Erden A,et al.Impact of perioperative lidocaine infusion and bis monitorization on remifentanil dosage in hypotensive anesthesia〔J〕.Eur Rev Med Pharmacol Sci,2014,18(4):559-565.
[7] Vaghari BA,Ahmed OI,Wu CL.Regional anesthesia-analgesia:relationship to cancer recurrence and infection〔J〕.Anesthesiol Clin,2014,32(4):841-851.
[8] Maserejian NN,Shrader P,Brown OA,et al.Dental sealants and composite restorations and longitudinal changes in immune function markers in children〔J〕.Int J Paediatr Dent,2014,24(3):215-225.
[9] Zhang WL,Liu MY,Zhang ZC,et al.Effect of different anesthesia methods on erythrocyte immune function in mice〔J〕.Asian Pac J Trop Med,2013,6(12):995-998.
[10] Fang F,Jie G,Xing B,et al.Effect and clinical significance of fast-track surgery combined with laparoscopic radical gastrectomy on the plasma level of vascular endothelial growth factor in gastric antrum cancer〔J〕.Springerplus,2016,5(1):1-5.
[11] Huang Z,Xie Y,You J,et al.Clinical significance of ropivacaine local infiltration for postoperative analgesia after total laparoscopic radical gastrectomy in elderly patients〔J〕.Zhonghua Yi Xue Za Zhi,2014,94(28):2188-2192.
(編輯:甘 艷)
Effect of Balance Anesthesia and Total Intravenous Anesthesia on Blood Gas and Immune Function of Gastric Cancer Patients Treated with Laparoscopic Radical Gastrectomy
MAYulin,WUChunbin.
AnkangCentralHospital,Ankang,725000
Objective To investigate the effect of balance anesthesia and total intravenous anesthesia on blood gas and immune function of gastric cancer patients treated with laparoscopic radical gastrectomy.Methods 80 cases of patients with gastric cancer were divided into 2 groups according to the different methods of anesthesia,the observation group used balance anesthesia,the control group used total intravenous anesthesia.The immune function of the groups before and after anesthesia,and the change of blood gas analysis before and after CO2pneumoperitoneum were observed.Results The NK,CD3+,CD4+ and CD4+/CD8+of the 2 groups were significantly decreased(P<0.05)and the control group was more obvious(P<0.05);the immune function indexes of the 2 groups 72 h after surgery were significantly higher(P<0.05);the blood gas analysis of the observation group before and after pneumoperitoneum had no significant difference(P>0.05),the pH of the control group increased significantly(P<0.05),CO2partial pressure,base excess and the amount of CO2decreased significantly(P<0.05).ConclusionThe effect of balance anesthesia on patients undergoing laparoscopic radical gastrectomy is better than total intravenous anesthesia,the immune function was suppressed and the blood gas analysis index was stable.
Balance anesthesia;Total intravenous anesthesia;Laparoscopic radical gastrectomy;Blood gas;Immune function
725000 陜西省安康市中心醫(yī)院
10.3969/j.issn.1001-5930.2017.01.015
R735.2
A
1001-5930(2017)01-0048-03
2016-07-06
2016-12-15)